Drug intelligence / Profile preview

Huoxue Zhitong Patch

Development stage: Unknown
Lead developer: Beijing Jiuneng Tianyuan Technology
Modality: Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration: Topical

Overview

Huoxue Zhitong Patch (活血止痛膏), also known by the brand name Jingdu Qilintang (京都麒麟堂), is an approved topical traditional Chinese medicine (TCM) patch developed and commercialized by Beijing Jiuneng Tianyuan Technology. Formulated with a blend of traditional Chinese herbs (including dry ginger, angelica, frankincense, and myrrh), the patch is designed to promote blood circulation, resolve blood stasis, reduce swelling, and alleviate pain. It is indicated for the relief of muscle aches, joint pain, rheumatic pain, and localized swelling or numbness.

Brand names: Jingdu Qilintang京都麒麟堂
Other names: Huoxue Zhitong GaoHuoxue Zhitong Plaster活血止痛膏

Beyond the preview

Go deeper on Huoxue Zhitong Patch.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Huoxue Zhitong Patch.